Joseph M. Miller

2018

In 2018, Joseph M. Miller earned a total compensation of $673K as Chief Financial Officer, Principal Executive Officer and Principal Financial Officer at Avalo Therapeutics.

Compensation breakdown

Bonus$61,370
Option Awards$255,515
Salary$153,600
Stock Awards$202,500
Total$672,985

Miller received $255.5K in option awards, accounting for 38% of the total pay in 2018.

Miller also received $61.4K in bonus, $153.6K in salary and $202.5K in stock awards.

Rankings

In 2018, Joseph M. Miller's compensation ranked 10,874th out of 14,244 executives tracked by ExecPay. In other words, Miller earned more than 23.7% of executives.

ClassificationRankingPercentile
All
10,874
out of 14,244
24th
Division
Manufacturing
4,386
out of 5,765
24th
Major group
Chemicals And Allied Products
1,655
out of 2,128
22nd
Industry group
Drugs
1,404
out of 1,817
23rd
Industry
Pharmaceutical Preparations
1,079
out of 1,391
22nd
Source: SEC filing on June 19, 2019.

Miller's colleagues

We found six more compensation records of executives who worked with Joseph M. Miller at Avalo Therapeutics in 2018.

2018

Peter Greenleaf

Avalo Therapeutics

Chief Executive Officer

2018

Mariam Morris

Avalo Therapeutics

Chief Financial Officer

2018

James Harrell

Avalo Therapeutics

Executive Vice President, Marketing and External Communications

2018

Pericles Calias

Avalo Therapeutics

Chief Scientific Officer

2018

Robert Moscato

Avalo Therapeutics

Chief Operating Officer

2018

Simon Pedder

Avalo Therapeutics

Chairman

News

You may also like